The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kitagawa-Sakakida, S.
Right arrow Articles by Schwartz, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitagawa-Sakakida, S.
Right arrow Articles by Schwartz, R. H.

The Journal of Immunology, Vol 157, Issue 6 2328-2339, Copyright © 1996 by American Association of Immunologists


ARTICLES

Multifactor cis-dominant negative regulation of IL-2 gene expression in anergized T cells

S Kitagawa-Sakakida and RH Schwartz
Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.

The molecular mechanism underlying IL-2 transcriptional blockade in anergic T cell clones is not fully understood. To examine whether an active negative regulatory process occurs, we created a reporter construct containing as an enhancer four copies of the NF-AT site and one copy of the octamer site (4X NF-AT-Oct). This construct was only slightly reduced (1.3-fold) in its expression when stimulated under anergic conditions, while a whole mouse IL-2 enhancer construct showed a reduction of 4.3-fold. Addition of the -176 to -96 sequence to the 4X NF-AT-Oct construct did not impart the ability to be affected by anergy, but addition of the -236 to -96 sequence did, demonstrating that anergy is an active inhibitory process and that more than the presence of the -150 AP-1 binding site (-152 to -147) is required to mediate the effect. Mutational studies of the -236 to -96 sequence indicated that the presence of both the -130 AP-1-like site (-187 to - 181) and the -150 proximal AP-1 site were necessary to observe anergy. Because the -180 site is not required for trans-activation, it was possible to confirm by mutation in the normal mouse IL-2 enhancer that this site is absolutely essential for anergy induction. The simplest model to explain these results is that anergy is mediated by a complex of multiple transcription factors that exert a cis-acting dominant negative regulatory effect on the trans-activation of the IL-2 gene.


This article has been cited by other articles:


Home page
BloodHome page
S.-M. Lee, B. Gao, and D. Fang
FoxP3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1
Blood, April 1, 2008; 111(7): 3599 - 3606.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Thomas, N. Chunder, C. Chen, S. E. Umetsu, S. Winandy, and A. D. Wells
Ikaros Enforces the Costimulatory Requirement for IL2 Gene Expression and Is Required for Anergy Induction in CD4+ T Lymphocytes
J. Immunol., December 1, 2007; 179(11): 7305 - 7315.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Bostik, E. S. Noble, S. T. Stephenson, F. Villinger, and A. A. Ansari
CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys Produce More IL-2 Than Cells from Disease-Susceptible Species: Involvement of p300 and CREB at the Proximal IL-2 Promoter in IL-2 Up-Regulation
J. Immunol., June 15, 2007; 178(12): 7720 - 7729.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Dillon, V. Karpitski, S. A. Wetzel, D. C. Parker, A. S. Shaw, and P. J. S. Stork
Ectopic B-Raf Expression Enhances Extracellular Signal-regulated Kinase (ERK) Signaling in T Cells and Prevents Antigen-presenting Cell-induced Anergy
J. Biol. Chem., September 19, 2003; 278(38): 35940 - 35949.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Abraham and J. Miller
Molecular Mechanisms of IL-2 Gene Regulation Following Costimulation Through LFA-1
J. Immunol., November 1, 2001; 167(9): 5193 - 5201.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Finch, P. E. Fields, and P. D. Greenberg
A Transcriptional Block in the IL-2 Promoter at the -150 AP-1 Site in Effector CD8+ T Cells
J. Immunol., June 1, 2001; 166(11): 6530 - 6536.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Bostik, A. E. Mayne, F. Villinger, K. P. Greenberg, J. D. Powell, and A. A. Ansari
Relative Resistance in the Development of T Cell Anergy in CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys
J. Immunol., January 1, 2001; 166(1): 506 - 516.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Attinger, H. Acha-Orbea, and H. R. MacDonald
Cutting Edge: Cell Autonomous Rather Than Environmental Factors Control Bacterial Superantigen-Induced T Cell Anergy In Vivo
J. Immunol., August 1, 2000; 165(3): 1171 - 1174.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Iacobelli, W. Wachsman, and K. L. McGuire
Repression of IL-2 Promoter Activity by the Novel Basic Leucine Zipper p21SNFT Protein
J. Immunol., July 15, 2000; 165(2): 860 - 868.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. G. Lerner, M. R. Horton, R. H. Schwartz, and J. D. Powell
Distinct Requirements for C-C Chemokine and IL-2 Production by Naive, Previously Activated, and Anergic T Cells
J. Immunol., April 15, 2000; 164(8): 3996 - 4002.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Korthauer, W. Nagel, E. M. Davis, M. M. Le Beau, R. S. Menon, E. O. Mitchell, C. A. Kozak, W. Kolanus, and J. A. Bluestone
Anergic T Lymphocytes Selectively Express an Integrin Regulatory Protein of the Cytohesin Family
J. Immunol., January 1, 2000; 164(1): 308 - 318.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Powell, C. G. Lerner, G. R. Ewoldt, and R. H. Schwartz
The -180 Site of the IL-2 Promoter Is the Target of CREB/CREM Binding in T Cell Anergy
J. Immunol., December 15, 1999; 163(12): 6631 - 6639.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. GUDMUNDSDOTTIR and L. A. TURKA
T Cell Costimulatory Blockade: New Therapies for TransplantRejection
J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1356 - 1365.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. D. Powell, C. G. Lerner, and R. H. Schwartz
Inhibition of Cell Cycle Progression by Rapamycin Induces T Cell Clonal Anergy Even in the Presence of Costimulation
J. Immunol., March 1, 1999; 162(5): 2775 - 2784.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Bonnard, L. Haughn, and M. Julius
CD4-Mediated Inhibiton of IL-2 Production in Activated T Cells
J. Immunol., February 1, 1999; 162(3): 1252 - 1260.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. G. Telander, E.-N. Malvey, and D. L. Mueller
Evidence for Repression of IL-2 Gene Activation in Anergic T Cells
J. Immunol., February 1, 1999; 162(3): 1460 - 1465.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Gonsky, R. L. Deem, C. C. W. Hughes, and S. R. Targan
Activation of the CD2 Pathway in Lamina Propria T Cells Up-Regulates Functionally Active AP-1 Binding to the IL-2 Promoter, Resulting in Messenger RNA Transcription and IL-2 Secretion
J. Immunol., May 15, 1998; 160(10): 4914 - 4922.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.